Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.19 USD | -1.73% | +6.31% | +60.77% |
11:49am | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
May. 29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.77% | 1.06B | |
+18.36% | 125B | |
+14.71% | 108B | |
-6.77% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-13.96% | 16.34B | |
+0.01% | 13.56B | |
+25.14% | 11.59B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Insider Sold Shares Worth $163,498, According to a Recent SEC Filing